# Hideki Hirakata

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hideki-hirakata/

## Facts

| Field | Value |
| --- | --- |
| Citations | 9,406 |
| Field | Dialysis and Renal Disease Management |
| h-index | 53 |
| i10-index | 124 |
| Last Known Institution | Saiseikai Fukuoka General Hospital |
| OpenAlex ID | https://openalex.org/A5113820739 |
| Works | 230 |

## Researcher papers

- [Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease](https://scholariq.org/papers/estimation-of-glomerular-filtration-rate-by-the-mdrd-study-equation-modified-for/)
- [A Novel Superoxide-producing NAD(P)H Oxidase in Kidney](https://scholariq.org/papers/a-novel-superoxide-producing-nad-p-h-oxidase-in-kidney/)
- [Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder](https://scholariq.org/papers/clinical-practice-guideline-for-the-management-of-chronic-kidney-disease-mineral/)
- [Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study](https://scholariq.org/papers/chronic-kidney-disease-and-cardiovascular-disease-in-a-general-japanese/)
- [Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient](https://scholariq.org/papers/prevalence-of-chronic-kidney-disease-ckd-in-the-japanese-general-population/)
- [2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease](https://scholariq.org/papers/2008-japanese-society-for-dialysis-therapy-guidelines-for-renal-anemia-in/)
- [Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus](https://scholariq.org/papers/th1-th2-balance-of-peripheral-t-helper-cells-in-systemic-lupus-erythematosus/)
- [2015 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease](https://scholariq.org/papers/2015-japanese-society-for-dialysis-therapy-guidelines-for-renal-anemia-in/)
- [Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death](https://scholariq.org/papers/direct-involvement-of-the-receptor-mediated-apoptotic-pathways-in-cisplatin/)
- [Predominance of Th1 immune response in diffuse proliferative lupus nephritis](https://scholariq.org/papers/predominance-of-th1-immune-response-in-diffuse-proliferative-lupus-nephritis/)
- [The effect of renin–angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy](https://scholariq.org/papers/the-effect-of-renin-angiotensin-system-blockade-on-the-incidence-of-end-stage/)
- [Secular trends in the incidence of end-stage renal disease and its risk factors in Japanese patients with immunoglobulin A nephropathy](https://scholariq.org/papers/secular-trends-in-the-incidence-of-end-stage-renal-disease-and-its-risk-factors/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Researcher university

- [Saiseikai Fukuoka General Hospital](https://scholariq.org/institutions/saiseikai-fukuoka-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.